Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Renovaro Inc. - Common Stock
(NQ:
RENB
)
0.5986
-0.0567 (-8.65%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Renovaro Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
February 15, 2024
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
Hit With Short Seller Report, Renovaro Biosciences Comments On Hindenburg's Opinion Piece
February 14, 2024
Renovaro Biosciences confronts Hindenburg's short report fallout, highlighting tech and business leaders joining the board. Despite false claims, the company asserts confidence.
Via
Benzinga
Statement of Renovaro Inc
February 14, 2024
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
BioMedNewsBreaks – Renovaro Inc. (NASDAQ: RENB) Fusing AI and Biotech to Accelerate Personalized Medicine, GEDiCube, Cyclomics Enter LOI to ‘Change the Field’
February 13, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
ROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
February 13, 2024
From
The Rosen Law Firm, P.A.
Via
Business Wire
Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
February 13, 2024
Shares of IPG Photonics Corporation (NASDAQ: IPGP) fell sharply during Tuesday’s session after the company reported mixed fourth-quarter financial results and issued soft first-quarter guidance.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
February 13, 2024
Via
Benzinga
Renovaro Biosciences Faces Turmoil After Hindenburg Report Accusing Questionable Merger And Governance, Stock Crashes
February 13, 2024
Renovaro Biosciences navigates challenges – from a controversial merger with GEDi Cube to allegations of securities law violations.
Via
Benzinga
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
February 13, 2024
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine
February 13, 2024
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
Patients with Swelling Disorder See New Gene Therapy as Godsend
February 07, 2024
Via
Investor Brand Network
Study Explains Why Immunotherapy Could Trigger Colitis in Cancer Patients
January 25, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Announces Results of Special Meeting
January 25, 2024
Via
Investor Brand Network
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
January 25, 2024
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) Releases CEO Shareholder Message
January 16, 2024
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Message from Renovaro Bioscience, Inc.’s CEO, The Hon. Mark Dybul, MD
January 16, 2024
Accelerating Healthcare With Award-Winning AI: Big Steps Forward In 2023 And The Early Days Of 2024
From
Renovaro Biosciences Inc.
Via
GlobeNewswire
Fruit Fly Study Opens Door to Novel Immunotherapy Approach Against Cancer
January 12, 2024
Via
Investor Brand Network
RENOVARO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Renovaro Biosciences Inc. - RENB
January 10, 2024
From
Kahn Swick & Foti, LLC
Via
Business Wire
Study Shows Ongoing Benefits Once Immunotherapy Stops
January 02, 2024
Via
Investor Brand Network
Oncologist Explores Whether Including Fiber in Diets Boosts Immunotherapy Outcomes
December 19, 2023
Via
Investor Brand Network
Researchers Harnessing Immune System to Fight Cancer More Effectively
December 07, 2023
Via
Investor Brand Network
Study Says Patients on Gene Therapy Need Long-Term Monitoring
November 27, 2023
Via
Investor Brand Network
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB) CEO Featured Guest in Recent Proactive Interview
November 22, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Poised to Spearhead Advancements in Battle Against Diseases, Harness Cutting-Edge AI Technology
November 21, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMedNewsBreaks – Renovaro BioSciences Inc. (NASDAQ: RENB) Eyes Opportunity in Largely Untapped Precision Medicine Market
November 17, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Unlocking AI investment opportunities in healthcare
November 16, 2023
AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.
Via
MarketBeat
Topics
Artificial Intelligence
ETFs
Exposures
Artificial Intelligence
How Immunotherapy Is Cementing a Role in Cancer Treatment
November 13, 2023
Via
Investor Brand Network
Renovaro Biosciences Inc. (NASDAQ: RENB) CEO Provides Update on Combination with AI Expert GEDiCube Intl Ltd. in Letter to Shareholders
November 10, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
BioMedNewsBreaks — Renovaro BioSciences Inc. (NASDAQ: RENB), GEDi Cube Combine to Transform Medicine Through AI and Biotherapeutics
November 08, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Renovaro Biosciences Inc. (NASDAQ: RENB) Announces Three New Members to Board of Directors as Definitive Agreement with GEDiCube Announced
November 06, 2023
Via
Investor Brand Network
Topics
Artificial Intelligence
Derivatives
Exposures
Artificial Intelligence
Derivatives
< Previous
1
2
3
4
5
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.